Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease - PubMed (original) (raw)
. 1999 Apr-Jun;20(2-3):239-47.
Affiliations
- PMID: 10385887
Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease
J M Gorell et al. Neurotoxicology. 1999 Apr-Jun.
Abstract
A population-based case-control study was conducted in the Henry Ford Health System (HFHS) in metropolitan Detroit to assess occupational exposures to manganese, copper, lead, iron, mercury and zinc as risk factors for Parkinson's disease (PD). Non-demented men and women 50 years of age who were receiving primary medical care at HFHS were recruited, and concurrently enrolled cases (n = 144) and controls (n = 464) were frequency-matched for sex, race and age (+/- 5 years). A risk factor questionnaire, administered by trained interviewers, inquired about every job held by each subject for 6 months from age 18 onward, including a detailed assessment of actual job tasks, tools and environment. An experienced industrial hygienist, blinded to subjects' case-control status, used these data to rate every job as exposed or not exposed to one or more of the metals of interest. Adjusting for sex, race, age and smoking status, 20 years of occupational exposure to any metal was not associated with PD. However, more than 20 years exposure to manganese (Odds Ratio [OR] = 10.61, 95% Confidence Interval [CI] = 1.06, 105.83) or copper (OR = 2.49, 95% CI = 1.06,5.89) was associated with PD. Occupational exposure for > 20 years to combinations of lead-copper (OR = 5.24, 95% CI = 1.59, 17.21), lead-iron (OR = 2.83, 95% CI = 1.07,7.50), and iron-copper (OR = 3.69, 95% CI = 1.40,9.71) was also associated with the disease. No association of occupational exposure to iron, mercury or zinc with PD was found. A lack of statistical power precluded analyses of metal combinations for those with a low prevalence of exposure (i.e., manganese, mercury and zinc). Our findings suggest that chronic occupational exposure to manganese or copper, individually, or to dual combinations of lead, iron and copper, is associated with PD.
Similar articles
- Occupational exposures to metals as risk factors for Parkinson's disease.
Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, Richardson RJ. Gorell JM, et al. Neurology. 1997 Mar;48(3):650-8. doi: 10.1212/wnl.48.3.650. Neurology. 1997. PMID: 9065542 Clinical Trial. - Occupations and Parkinson's disease: a multi-center case-control study in South Korea.
Park J, Yoo CI, Sim CS, Kim HK, Kim JW, Jeon BS, Kim KR, Bang OY, Lee WY, Yi Y, Jung KY, Chung SE, Kim Y. Park J, et al. Neurotoxicology. 2005 Jan;26(1):99-105. doi: 10.1016/j.neuro.2004.07.001. Neurotoxicology. 2005. PMID: 15527877 - Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.
Taylor CA, Saint-Hilaire MH, Cupples LA, Thomas CA, Burchard AE, Feldman RG, Myers RH. Taylor CA, et al. Am J Med Genet. 1999 Dec 15;88(6):742-9. Am J Med Genet. 1999. PMID: 10581500 - Searching for a relationship between manganese and welding and Parkinson's disease.
Jankovic J. Jankovic J. Neurology. 2005 Jun 28;64(12):2021-8. doi: 10.1212/01.WNL.0000166916.40902.63. Neurology. 2005. PMID: 15985567 Review. - Occupational metal exposures and the risk of Parkinson's disease.
Gorell JM, Rybicki BA, Cole Johnson C, Peterson EL. Gorell JM, et al. Neuroepidemiology. 1999;18(6):303-8. doi: 10.1159/000026225. Neuroepidemiology. 1999. PMID: 10545782 Review.
Cited by
- The Nrf2/SKN-1-dependent glutathione S-transferase π homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism.
Settivari R, VanDuyn N, LeVora J, Nass R. Settivari R, et al. Neurotoxicology. 2013 Sep;38:51-60. doi: 10.1016/j.neuro.2013.05.014. Epub 2013 May 27. Neurotoxicology. 2013. PMID: 23721876 Free PMC article. - "Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies".
Peres TV, Schettinger MR, Chen P, Carvalho F, Avila DS, Bowman AB, Aschner M. Peres TV, et al. BMC Pharmacol Toxicol. 2016 Nov 4;17(1):57. doi: 10.1186/s40360-016-0099-0. BMC Pharmacol Toxicol. 2016. PMID: 27814772 Free PMC article. Review. - Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates.
Schneider JS, Decamp E, Koser AJ, Fritz S, Gonczi H, Syversen T, Guilarte TR. Schneider JS, et al. Brain Res. 2006 Nov 6;1118(1):222-31. doi: 10.1016/j.brainres.2006.08.054. Epub 2006 Sep 15. Brain Res. 2006. PMID: 16978592 Free PMC article. - Maintaining Translational Relevance in Animal Models of Manganese Neurotoxicity.
Taylor CA, Tuschl K, Nicolai MM, Bornhorst J, Gubert P, Varão AM, Aschner M, Smith DR, Mukhopadhyay S. Taylor CA, et al. J Nutr. 2020 Jun 1;150(6):1360-1369. doi: 10.1093/jn/nxaa066. J Nutr. 2020. PMID: 32211802 Free PMC article. - Serum zinc deficiency could be associated with dementia conversion in Parkinson's disease.
Lee J, Park S, Jang W. Lee J, et al. Front Aging Neurosci. 2023 Apr 27;15:1132907. doi: 10.3389/fnagi.2023.1132907. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37181629 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical